Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

BACKGROUND: Metabolic and cardiovascular side effects have been noted with the use of second generation antipsychotics (SGAs) and mood stabilizers. Since Omega-3 fatty acids have been known to prevent some cardiovascular risks, this preliminary study was designed to evaluate the cardiovascular benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Faghihi, Toktam, Jahed, Adel, Mahmoudi-Gharaei, Javad, Sharifi, Vandad, Akhondzadeh, Shahin, Ghaeli, Padideh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555734/
https://www.ncbi.nlm.nih.gov/pubmed/23351198
http://dx.doi.org/10.1186/2008-2231-20-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555734/
https://www.ncbi.nlm.nih.gov/pubmed/23351198
http://dx.doi.org/10.1186/2008-2231-20-43

Ejemplares similares